Trial and Error and Algorithm
Clinical Trials: Overview
Clinical Trials
Introduction to Nuclear Reprogramming
Methods of Nuclear Reprogramming
Somatic to iPS Cell Reprogramming
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 12, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Dongying Chen1, Michael Simons2
1From the Department of Internal Medicine and Department of Cell Biology, Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT.
No abstract available in PubMed .